2seventy bio (TSVT) Short Interest Ratio & Short Volume

Short interest is the volume of 2seventy bio shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 7,290,000 shares of TSVT short. 15.15% of 2seventy bio's shares are currently sold short. Learn More on 2seventy bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSVT shares currently have a short interest ratio of 13.0. Learn More on 2seventy bio's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.15% of 2seventy bio's floating shares are currently sold short.

2seventy bio saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 7,290,000 shares, an increase of 24.4% from the previous total of 5,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2seventy bio currently has issued a total of 51,405,000 shares. Some of 2seventy bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 2seventy bio currently has a public float of 48,110,000 shares.

15.15% of 2seventy bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to 2seventy bio: Pacira BioSciences, Inc. (13.96%), AbCellera Biologics Inc. (8.61%), Immunome, Inc. (27.47%), Liquidia Co. (15.02%), Cogent Biosciences, Inc. (10.87%), Harrow, Inc. (15.74%), 89bio, Inc. (6.26%), Olema Pharmaceuticals, Inc. (13.07%), CureVac (8.04%), Dianthus Therapeutics, Inc. (16.33%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling TSVT is an investing strategy that aims to generate trading profit from 2seventy bio as its price is falling. TSVT shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for 2seventy bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TSVT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSVT, twice per month. The most recent reporting period available is July, 15 2024.